Clinical Trials Directory

Trials / Completed

CompletedNCT05867888

Shock Wave Therapy Versus Low Level Laser Therapy in Patients With Plantar Fasciitis

Effect of Shock Wave Therapy Versus Low Level Laser Therapy in Patients With Plantar Fasciitis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
75 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
40 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Both shock wave therapy and low level laser therapy in plantar fasciitis are effective in improvement of such cases without any side effects but there are no previously published studies on the use of shock wave therapy versus low level laser therapy in plantar fasciitis and, hence, evidence of its acceptability and effectiveness compared with each other remains to be established.

Detailed description

Plantar fasciitis is a result of degenerative irritation of the plantar fascia origin at the medial calcaneal tuberosity of the heel as well as the surrounding perifascial structures, it is a common problem accounting for approximately one million patient visits per year, it is often an overuse injury. As a result tight gastrocnemius, soleus, and/or other posterior leg muscles have also been commonly found in patients with this condition. Shock wave therapy is thought to provide long lasting analgesia and stimulate the healing process, Low level laser therapy has been used to relieve pain caused by plantar fasciitis, also stretching of the shortened and contracted plantar flexors may positively influence an individual's functional activities of daily living and decrease the risk of injury.

Conditions

Interventions

TypeNameDescription
OTHERconventional therapyconventional therapy ( instructions, ice application, deep tissue massage, stretching exercises, joint mobilization and isometric exercises )
OTHERshock wave therapyAcoustic waves (shock waves) that can carry energy and can propagate through tissues promote healing effects.
OTHERlow level laser therapyThe application of light to a biologic system to promote tissue regeneration, reduce inflammation and relieve pain.

Timeline

Start date
2023-05-01
Primary completion
2023-10-10
Completion
2023-10-10
First posted
2023-05-22
Last updated
2024-02-21

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05867888. Inclusion in this directory is not an endorsement.